darbepoetin medicine

Product Description

Cresp 40 Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.

Efficacy in Treating Anemia

Darbepoetin offers significant benefit in managing anemia related to chronic kidney disease and chemotherapy. Its mechanism involves stimulating red blood cell production, helping improve hemoglobin levels and alleviate fatigue associated with anemia. The long-acting formulation allows for less frequent dosing, enhancing patient compliance and comfort during treatment.


High Standards & Safe Preparation

Manufactured under GMP guidelines in India, darbepoetin guarantees consistent quality. The medicine is provided as a clear, colorless, odorless injectable solution, either in pre-filled syringes or vials. Proper storage (2C8C, not frozen) and disposal are essential to maintain safety and efficacy, in accordance with medical waste protocols.


Usage and Administration Guidance

Darbepoetin is intended for subcutaneous or intravenous injection, as prescribed by a healthcare provider. Dosage forms and frequencies are tailored to patient needs and hemoglobin response, with regular monitoring required. It is contraindicated in individuals with uncontrolled hypertension or known hypersensitivity to darbepoetin alfa, and precautions are necessary in patients with cardiovascular conditions or seizure history.